Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Quoin Pharmaceuticals

8.38
-0.0900-1.06%
Post-market: 8.380.00000.00%19:20 EDT
Volume:9.47K
Turnover:78.68K
Market Cap:4.93M
PE:-0.21
High:8.58
Open:8.14
Low:8.09
Close:8.47
Loading ...
OverviewCompanyNewsFilings

Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study

GlobeNewswire
·
14 Jan

PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials

GlobeNewswire
·
08 Jan

Buy Rating Reaffirmed for Quoin Pharmaceuticals Amid Promising QRX003 Developments and Market Potential

TIPRANKS
·
08 Jan

Quoin Pharmaceuticals Announces Additional Positive Interim Data from Ongoing Open-Label Netherton Syndrome Clinical Study

GlobeNewswire
·
06 Jan

Quoin Pharmaceuticals Prices $6.8 Million Equity Offering -- Shares Fall

MT Newswires Live
·
21 Dec 2024

Quoin Pharmaceuticals prices 15.1M ADSs at 45c in public offering

TIPRANKS
·
20 Dec 2024

Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering

GlobeNewswire
·
20 Dec 2024

Quoin Pharmaceuticals announces FDA clearance to initiate QRX003 study

TIPRANKS
·
19 Dec 2024

Quoin Pharmaceuticals Announces Positive Interim Data from Two Ongoing Netherton Syndrome Clinical Studies

GlobeNewswire
·
18 Dec 2024

Quoin Pharmaceuticals files to sell 19.23M ordinary shares

TIPRANKS
·
12 Dec 2024

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
May 13, 2025 Pre-Market
Split&Reverse Split
Apr 09, 2025 35 for 1
Financial Report Announcement
Mar 13, 2025 Pre-Market
Financial Report Announcement
Nov 07, 2024 Pre-Market
Financial Report Announcement
Aug 08, 2024 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.48
Current
-0.80
Sector Average
47.67%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.48
Maximum
-0.12
+1 STD
0.89
Minimum
-17.35
-1 STD
-2.48
Average
-0.80

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.